The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomy
Shugeng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yousheng Mao(Chinese Academy of Medical Sciences & Peking Union Medical College), Gening Jiang(Tongji University), Hyun Koo Kim(Columbia University Irving Medical Center), Martínez I. Garutti(Fujian Medical University), Zhongmin Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Dominique Gossot(Sir Run Run Shaw Hospital), Weimin Mao(St James's University Hospital), Mohsen Ibrahim(Sir Run Run Shaw Hospital), Jin‐Shing Chen(National Taipei University), Andrea Imperatori(University of Insubria), John B. Downs(Chinese Academy of Medical Sciences & Peking Union Medical College), Pier Luigi Filosso(University of Turin), Wentao Fang(Bristol-Myers Squibb (Germany)), Ying Chai(Second Affiliated Hospital of Zhejiang University), Seth Force(Emory Healthcare), Qiang Li(Fernández-Vega Ophthalmological Institute), Kevin W. Lobdell, Bo Laksáfoss Holbek(St James's University Hospital), Deruo Liu(Roswell Park Comprehensive Cancer Center), Stephen D. Cassivi(Mayo Clinic), Pierre‐Emmanuel Falcoz(Chinese Academy of Medical Sciences & Peking Union Medical College), David T. Cooke(University of California Davis Medical Center), Lunxu Liu(Sichuan University), Eric Lim(Royal Brompton Hospital), Xiangning Fu(Tongji Hospital), Alessandro Brunelli(Marche Polytechnic University), Javier Aragón(Roswell Park Comprehensive Cancer Center), Zhongheng Zhang(Sir Run Run Shaw Hospital), Xiaofei Li(Air Force Medical University), Chun Chen(Fujian Medical University), Gang Chen(Guangxi Medical University), Zhijun Li(Fujian Medical University), Yin Li(Third Affiliated Hospital of Sun Yat-sen University), Chang Chen(Fujian Medical University), Jie He(Chinese Academy of Medical Sciences & Peking Union Medical College), Gaofeng Li(Sir Run Run Shaw Hospital), Hui Li(State Key Laboratory of Natural Medicine), Haiquan Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianxing He(Southern Medical University), Yunchao Huang(Kunming Medical University), Danqing Li(Dalian Medical University), Hongjing Jiang(Tianjin Medical University Cancer Institute and Hospital), Mahmoud Ismail(Guangdong General Hospital), Chia-Chuan Liu(National Cheng Kung University), Henrik Jessen Hansen(Chinese Academy of Medical Sciences & Peking Union Medical College), Yongyi Liu(China Medical University), Diego González-Rivas(Universidade da Coruña), Haitao Ma(St James's University Hospital), Jian Hu(First Affiliated Hospital Zhejiang University)
Cited by 58
Related Papers
Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Guidelines for Perioperative Care in Cardiac Surgery
|JAMA Surgery|2019|1.2k
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2023|1k